Having an understanding of the progression of lung cancer and the treatment methods helps the patients and their families to ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Lung cancer affects many non-smokers, especially women, due to factors like secondhand smoke and environmental pollutants.

As technology and genomic research progress, these diagnostics may become more accessible, enabling broader adoption across ...

AstraZeneca and Daiichi Sankyo shared the pooled analysis behind the refiling of their TROP2 antibody-drug conjugate (ADC) ...

The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.

Incyte is abandoning its ALK2 blocker zilurgisertib, which it was trialing for myelofibrosis-associated anemia, while iTeos ...

Project EVOLVE findings show how AI-driven real-world data analysis, combined with targeted educational interventions, can ...

Prevention, screening and treatment advances combined stopped 5.94 million deaths from cancer in the United States from 1975 through 2020.

Top Forbes SHOOK advisors pledge $1.5M to fund kidney cancer treatment at Sloan Kettering Cancer Center in New York ...

Analyst Jason McCarthy of Maxim Group maintained a Buy rating on Immutep (IMMP – Research Report), retaining the price target of $12.00.Pick ...

Dizal announces positive pooled data of sunvozertinib in EGFR TKI-resistant NSCLC: Shanghai, China Friday, December 13, 2024, 18:00 Hrs [IST] Dizal, a biopharmaceutical company co ...